Literature DB >> 6328641

Analysis of the quantity of antiviral antibodies from mink infected with different Aleutian disease virus strains.

B Aasted, G S Tierney, M E Bloom.   

Abstract

Mink persistently infected with Aleutian disease virus (ADV) develop hypergammaglobulinaemia and immune complex disease. Radiolabelled antibodies from mink infected with ADV-G, DK, Pullman , and Utah I strains of ADV were reacted against all four ADV strains in radioimmunoassay (RIA). The amount of anti-ADV antibody in two equally hypergammaglobulinaemic serum pools varied from 13% (anti- Pullman ) to 57% (anti-Utah I). Serum pools from two other sources (anti-DK and anti-ADV-G), although less hypergammaglobulinaemic , had 5% and 13%, respectively, indicating that 43-95% of the Ig in the sera of mink with AD was not specific antibody to ADV structural antigens. The possibility of a general polyclonal activation of the humoral immune system is being discussed. Comparison of plateau RIA binding levels for the four serum pools against the four viral antigens suggested three patterns of reactivity: DK and Utah I reacted similarly, but Pullman and ADV-G reacted serologically different.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328641     DOI: 10.1111/j.1365-3083.1984.tb00947.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  12 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Replication of Aleutian mink disease parvovirus in lymphoid tissues of adult mink: involvement of follicular dendritic cells and macrophages.

Authors:  S Mori; J B Wolfinbarger; M Miyazawa; M E Bloom
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Analysis of molecularly cloned DNA reveals minor differences among three virus strains of Aleutian disease of mink parvovirus. Brief report.

Authors:  M E Bloom; D Lechner; D L Wiedbrauk; J B Wolfinbarger
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Pathogenesis of Aleutian mink disease parvovirus infection: effects of suppression of antibody response on viral mRNA levels and on development of acute disease.

Authors:  S Alexandersen; T Storgaard; N Kamstrup; B Aasted; D D Porter
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

5.  Unusual, high genetic diversity of Aleutian mink disease virus.

Authors:  A Olofsson; C Mittelholzer; L Treiberg Berndtsson; L Lind; T Mejerland; S Belák
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

6.  Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions.

Authors:  M E Bloom; D A Martin; K L Oie; M E Huhtanen; F Costello; J B Wolfinbarger; S F Hayes; M Agbandje-McKenna
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink.

Authors:  M E Bloom; R E Race; B Aasted; J B Wolfinbarger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

8.  Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation.

Authors:  M E Bloom; S M Best; S F Hayes; R D Wells; J B Wolfinbarger; R McKenna; M Agbandje-McKenna
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Interstitial nephritis in Aleutian mink disease. Possible role of cell-mediated immunity against virus-infected tubular epithelial cells.

Authors:  S Mori; M Nose; M Miyazawa; M Kyogoku; J B Wolfinbarger; M E Bloom
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

10.  Identification of Aleutian mink disease parvovirus transcripts in macrophages of infected adult mink.

Authors:  H Kanno; J B Wolfinbarger; M E Bloom
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.